Pharmascience Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pharmascience Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7575
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pharmascience Inc (Pharmascience) is a pharmaceutical company which develops, manufactures and markets generic pharmaceutical products. The company offers generic, prescription, over-the-counter and private label OTC products. It offers drugs in therapeutic areas of anti-inflammatory, cancer, cardiovascular, pain management, allergies, anti-infectives, gastro-intestinal, cough and cold, and others. The company provides customer support, medical equipment selection, advertising, and pharmacy nursing support services. It also markets and distribute its products to healthcare institutions, drug store retail chains, and other pharmacies across Canada. It operates research, development and production facilities in Montreal. Pharmascience is headquartered in Montreal, Quebec, Canada.

Pharmascience Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmascience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmascience Inc, Medical Devices Deals, 2012 to YTD 2018 10
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pharmascience Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Helix BioPharma Completes Sale Of Rivex Pharma To Pharmascience For US$8.6 Million 13
Venture Financing 15
RDD Pharma Raises USD9.5 Million in Series B Financing 15
Edesa Biotech Raises USD5.7 Million in Series A Financing 16
Pharmaceutics International Raises USD93 Million in Venture Financing 17
Bionpharma Secures USD8.73 Million in Venture Funding 19
Bion Pharma Raises USD21 Million in Venture Financing 20
Partnerships 21
PendoPharm Enters into Distribution Agreement with Tillotts Pharma 21
Anika Therapeutics Enters into Agreement with PendoPharm 22
Pendopharm Enters into Distribution Agreement with Sanofi-aventis Canada 23
Pharmascience Enters Into Co-Development Agreement With University Of Montreal 24
Pharmascience Enters Into Joint Venture With Korea Kolmar To Form Pharmascience Korea 25
Licensing Agreements 26
Pharmascience Enters into Licensing Agreement with Cosmo Pharma 26
Pendopharm Enters into Licensing Agreement with Edesa Biotech 27
Pharmascience Signs Technology Transfer Memorandum of Understanding with Iquego 28
Sigmoid Pharma Enters into Licensing Agreement with PendoPharm for CyCol 29
Paion Exercises Option for Licensing Agreement with PendoPharm for Remimazolam 30
Redx Pharma Enters Into Licensing Agreement With Pharmascience For Cancer Program 31
DARA BioSciences Enters Into Licensing Agreement With Uman Pharma For Gemcitabine 32
Equity Offering 33
Sigmoid Pharma Raises USD6.3 Million in Private Placement 33
Paion Raises USD5.4 Million in Private Placement of Shares 34
Acquisition 35
Pharmascience Acquires 10.4% Stake In Bellus Health For US$17.4 Million 35
Pharmascience Inc – Key Competitors 37
Pharmascience Inc – Key Employees 38
Pharmascience Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 41
Legal and Regulatory 41
Jun 20, 2017: Pharmascience Acknowledges Non-Compliant (Nc) Rating Given To Its Montreal Royalmount Ave. Facility Health Canada 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Pharmascience Inc, Pharmaceuticals & Healthcare, Key Facts 2
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmascience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmascience Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmascience Inc, Medical Devices Deals, 2012 to YTD 2018 10
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Helix BioPharma Completes Sale Of Rivex Pharma To Pharmascience For US$8.6 Million 13
RDD Pharma Raises USD9.5 Million in Series B Financing 15
Edesa Biotech Raises USD5.7 Million in Series A Financing 16
Pharmaceutics International Raises USD93 Million in Venture Financing 17
Bionpharma Secures USD8.73 Million in Venture Funding 19
Bion Pharma Raises USD21 Million in Venture Financing 20
PendoPharm Enters into Distribution Agreement with Tillotts Pharma 21
Anika Therapeutics Enters into Agreement with PendoPharm 22
Pendopharm Enters into Distribution Agreement with Sanofi-aventis Canada 23
Pharmascience Enters Into Co-Development Agreement With University Of Montreal 24
Pharmascience Enters Into Joint Venture With Korea Kolmar To Form Pharmascience Korea 25
Pharmascience Enters into Licensing Agreement with Cosmo Pharma 26
Pendopharm Enters into Licensing Agreement with Edesa Biotech 27
Pharmascience Signs Technology Transfer Memorandum of Understanding with Iquego 28
Sigmoid Pharma Enters into Licensing Agreement with PendoPharm for CyCol 29
Paion Exercises Option for Licensing Agreement with PendoPharm for Remimazolam 30
Redx Pharma Enters Into Licensing Agreement With Pharmascience For Cancer Program 31
DARA BioSciences Enters Into Licensing Agreement With Uman Pharma For Gemcitabine 32
Sigmoid Pharma Raises USD6.3 Million in Private Placement 33
Paion Raises USD5.4 Million in Private Placement of Shares 34
Pharmascience Acquires 10.4% Stake In Bellus Health For US$17.4 Million 35
Pharmascience Inc, Key Competitors 37
Pharmascience Inc, Key Employees 38
Pharmascience Inc, Other Locations 39
Pharmascience Inc, Subsidiaries 39

List of Figures
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmascience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmascience Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Pharmascience Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Argonaut Gold Inc.:企業の戦略・SWOT・財務分析
    Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Buongiorno SpA:企業の戦略的SWOT分析
    Buongiorno SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Tuesday Morning Corporation (TUES):企業の財務・戦略的SWOT分析
    Tuesday Morning Corporation (TUES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Falco SD Holdings Co Ltd (4671):企業の財務・戦略的SWOT分析
    Summary Falco SD Holdings Co Ltd (Falco), formerly Falco Biosystems Ltd is a clinical testing and dispensing pharmacy service provider. The company offers services such as genetic testing, clinical trials, medical information systems development, and food sanitation and environmental testing. It pro …
  • Tosoh Bioscience Inc:企業の製品パイプライン分析2018
    Summary Tosoh Bioscience Inc (TBI), a subsidiary of Tosoh Corp, is a medical device company that offers diagnostic systems. The company provides analyzers, assays, immunoassay solutions, reagent technology, HbA1c solutions, ß-thalassemia testing, and HPLC technology. Its immunoassay solutions compri …
  • Sunflower Electric Power Corp:企業の戦略的SWOT分析
    Sunflower Electric Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Tower International Inc:企業の戦略的SWOT分析
    Tower International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Bone Therapeutics SA (BOTHE):企業の財務・戦略的SWOT分析
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. It offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fractures; and AL …
  • Instituto Costarricense de Electricidad:企業の戦略的SWOT分析
    Instituto Costarricense de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Vapo Oy:企業の戦略的SWOT分析
    Vapo Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Chang Hwa Commercial Bank, Ltd.:企業の戦略・SWOT・財務情報
    Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Werner Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • A2B Australia Limited
    A2B Australia Limited - Strategy, SWOT and Corporate Finance Report Summary A2B Australia Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Zurich UK:企業の戦略・SWOT・財務情報
    Zurich UK - Strategy, SWOT and Corporate Finance Report Summary Zurich UK - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Shield Therapeutics Plc (STX):企業の財務・戦略的SWOT分析
    Summary Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. The company’s product portfolio includes Feraccru, a stable, non …
  • DNO ASA (DNO):石油・ガス:M&Aディール及び事業提携情報
    Summary DNO ASA (DNO) is an oil and gas company that provides mineral properties exploration and development services. The company's services include selective and targeted drilling, fractured carbonate plays that are characteristic of the MENA region. It also provides operations in petroleum, shipp …
  • Pyramisa Hotels & Resorts:企業の戦略・SWOT・財務情報
    Pyramisa Hotels & Resorts - Strategy, SWOT and Corporate Finance Report Summary Pyramisa Hotels & Resorts - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Saudi Arabian Oil Co:企業の戦略的SWOT分析
    Saudi Arabian Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • RBC Bearings Inc (ROLL):企業の財務・戦略的SWOT分析
    Summary RBC Bearings Inc (RBC Bearings) is an industrial equipment company that manufactures and markets engineered precision bearings and products. The company offers products through industrial and aerospace division. Its industrial products include ball bearings, cam followers, collets and toolho …
  • Vision Ease LP:企業の戦略的SWOT分析
    Vision Ease LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆